Annual FCF
-$614.50 K
+$11.06 M+94.74%
December 1, 2023
Summary
- As of February 22, 2025, CYTO annual free cash flow is -$614.50 thousand, with the most recent change of +$11.06 million (+94.74%) on December 1, 2023.
- During the last 3 years, CYTO annual FCF has risen by +$7.58 million (+92.50%).
- CYTO annual FCF is now at all-time high.
Performance
CYTO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
N/A
June 1, 2024
Summary
- CYTO quarterly free cash flow is not available.
Performance
CYTO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
N/A
June 1, 2024
Summary
- CYTO TTM free cash flow is not available.
Performance
CYTO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CYTO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +94.7% | - | - |
| 3 y3 years | +92.5% | - | - |
| 5 y5 years | +96.0% | - | - |
CYTO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.7% | ||||
| 5 y | 5-year | at high | +96.7% | ||||
| alltime | all time | at high | +97.9% |
Altamira Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$614.50 K(-94.7%) | - | - |
| Dec 2022 | -$11.68 M(-37.2%) | - | - |
| Dec 2021 | -$18.60 M(+127.0%) | - | - |
| Dec 2020 | -$8.19 M(-30.4%) | - | - |
| Dec 2019 | -$11.78 M(-23.3%) | - | - |
| Dec 2018 | -$15.36 M(-38.7%) | -$3.95 M(-3.4%) | -$15.46 M(-12.3%) |
| Sep 2018 | - | -$4.09 M(+89.2%) | -$17.63 M(-6.6%) |
| Jun 2018 | - | -$2.16 M(-58.8%) | -$18.88 M(-18.7%) |
| Mar 2018 | - | -$5.25 M(-14.3%) | -$23.23 M(-6.3%) |
| Dec 2017 | -$25.08 M(-14.0%) | -$6.13 M(+14.8%) | -$24.80 M(-0.8%) |
| Sep 2017 | - | -$5.34 M(-18.1%) | -$24.99 M(-5.8%) |
| Jun 2017 | - | -$6.52 M(-4.4%) | -$26.54 M(-10.3%) |
| Mar 2017 | - | -$6.82 M(+7.9%) | -$29.60 M(-1.8%) |
| Dec 2016 | -$29.15 M | -$6.32 M(-8.2%) | -$30.15 M(-1.6%) |
| Sep 2016 | - | -$6.88 M(-28.2%) | -$30.65 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | -$9.58 M(+30.1%) | -$31.38 M(+2.4%) |
| Mar 2016 | - | -$7.37 M(+8.0%) | -$30.65 M(+2.4%) |
| Dec 2015 | -$29.14 M(+40.2%) | -$6.82 M(-10.4%) | -$29.94 M(+0.5%) |
| Sep 2015 | - | -$7.61 M(-13.9%) | -$29.79 M(+19.8%) |
| Jun 2015 | - | -$8.85 M(+32.9%) | -$24.86 M(+6.9%) |
| Mar 2015 | - | -$6.65 M(-0.2%) | -$23.25 M(+3.4%) |
| Dec 2014 | -$20.79 M(+30.3%) | -$6.67 M(+148.3%) | -$22.49 M(+9.2%) |
| Sep 2014 | - | -$2.69 M(-62.9%) | -$20.60 M(-7.7%) |
| Jun 2014 | - | -$7.24 M(+22.7%) | -$22.31 M(+14.2%) |
| Mar 2014 | - | -$5.90 M(+23.5%) | -$19.53 M(+27.9%) |
| Dec 2013 | -$15.95 M(+214.4%) | -$4.78 M(+8.6%) | -$15.27 M(+45.5%) |
| Sep 2013 | - | -$4.40 M(-1.4%) | -$10.50 M(+72.1%) |
| Jun 2013 | - | -$4.46 M(+172.9%) | -$6.10 M(+272.9%) |
| Mar 2013 | - | -$1.64 M | -$1.64 M |
| Dec 2012 | -$5.07 M | - | - |
FAQ
- What is Altamira Therapeutics annual free cash flow?
- What is the all time high annual FCF for Altamira Therapeutics?
- What is Altamira Therapeutics annual FCF year-on-year change?
- What is the all time high quarterly FCF for Altamira Therapeutics?
- What is the all time high TTM FCF for Altamira Therapeutics?
What is Altamira Therapeutics annual free cash flow?
The current annual FCF of CYTO is -$614.50 K
What is the all time high annual FCF for Altamira Therapeutics?
Altamira Therapeutics all-time high annual free cash flow is -$614.50 K
What is Altamira Therapeutics annual FCF year-on-year change?
Over the past year, CYTO annual free cash flow has changed by +$11.06 M (+94.74%)
What is the all time high quarterly FCF for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly free cash flow is -$1.64 M
What is the all time high TTM FCF for Altamira Therapeutics?
Altamira Therapeutics all-time high TTM free cash flow is -$1.64 M